Chewy, Inc.
Business
Chewy, Inc. operates an e-commerce platform that sells pet products and delivers pet health services to pet parents and veterinary partners. The company offers a wide assortment of retail products (food, treats, supplies), private brands, prescription and pharmacy services, telehealth (Connect with a Vet), CarePlus insurance and wellness plans, sponsored ads, PracticeHub for veterinarians, and Chewy Vet Care clinics. Key business areas include retail e-commerce, pet healthcare and pharmacy, veterinary services and practice solutions, and advertising/private brands. Chewy serves customers primarily through its websites and mobile applications with fulfillment centers across the U.S. and Canada, offering overnight and multi-day delivery and subscription Autoship distribution channels.
Summary from filing dated 2025-03-26
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2026 2026-01-31 | FY 2025 2025-01-31 | FY 2024 2024-01-31 | FY 2023 2023-01-31 | FY 2022 2022-01-31 |
|---|---|---|---|---|---|---|
| Net sales | 12,602 | 11,861 | 11,148 | 10,119 | 8,967 | |
| Cost of goods sold | 8,848 | 8,394 | 7,986 | 7,285 | 6,582 | |
| Gross profit | 3,754 | 3,468 | 3,162 | 2,834 | 2,385 | |
| Selling, general and administrative | 2,675 | 2,551 | 2,443 | 2,129 | 1,840 | |
| Advertising and marketing | 825 | 804 | 742 | 649 | 619 | |
| Total operating expenses | 3,500 | 3,355 | 3,185 | 2,778 | 2,459 | |
| Income (loss) from operations | 254 | 113 | −24 | 56 | −74 | |
| Interest and other income, net | 9 | 39 | 72 | — | — | |
| Income before income tax provision (benefit) | 263 | 152 | 48 | 53 | −75 | |
| Income tax provision (benefit) | 41 | −241 | 9 | 3 | 0 | |
| Net income | 223 | 393 | 40 | 50 | −75 | |
| Foreign currency translation adjustments | 800,000 | 500,000 | −400,000 | 0 | 0 | |
| Comprehensive income | 224 | 393 | 39 | 50 | −75 | |
| Basic (in dollars per share) | 0.54 | 0.93 | 0.09 | 0.12 | −0.18 | |
| Diluted (in dollars per share) | 0.52 | 0.91 | 0.09 | 0.12 | −0.18 | |
| Basic (in shares) | 414 | 421 | 429 | 422 | 417 | |
| Diluted (in shares) | 426 | 431 | 432 | 428 | 417 |
Consolidated Balance Sheet
| Concept | Trend | FY 2026 2026-01-31 | FY 2025 2025-01-31 | FY 2024 2024-01-31 | FY 2023 2023-01-31 | FY 2022 2022-01-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 860 | 596 | 602 | 332 | 603 | |
| Marketable securities | 19 | 900,000 | 532 | 347 | — | |
| Accounts receivable | 222 | 169 | 154 | 127 | 124 | |
| Inventories | 865 | 837 | 719 | 678 | 560 | |
| Prepaid expenses and other current assets | 70 | 60 | 97 | 41 | 37 | |
| Total current assets | 2,036 | 1,662 | 2,104 | 1,525 | 1,324 | |
| Property and equipment, net | 552 | 562 | 521 | 479 | 367 | |
| Operating lease right-of-use assets | 468 | 450 | 475 | 424 | 373 | |
| Goodwill | 39 | 39 | 39 | 39 | 0 | |
| Deferred tax assets | 232 | 258 | 0 | — | — | |
| Other non-current assets | 39 | 43 | 47 | 53 | 23 | |
| Total assets | 3,366 | 3,015 | 3,187 | 2,520 | 2,086 | |
| Trade accounts payable | 1,221 | 1,176 | 1,105 | 1,033 | 883 | |
| Accrued expenses and other current liabilities | 1,080 | 1,031 | 1,006 | 795 | 762 | |
| Total current liabilities | 2,302 | 2,207 | 2,111 | 1,828 | 1,645 | |
| Operating lease liabilities | 519 | 502 | 528 | 472 | 410 | |
| Other long-term liabilities | 48 | 44 | 38 | 60 | 16 | |
| Total liabilities | 2,869 | 2,753 | 2,677 | 2,360 | 2,072 | |
| Commitments and contingencies (Note 6) | — | — | — | — | — | |
| Preferred stock, $0.01 par value per share, 5,000,000 shares authorized, no shares issued and outstanding as of February 1, 2026 and February 2, 2025 | 0 | 0 | 0 | 0 | 0 | |
| Additional paid-in capital | 1,853 | 1,840 | 2,482 | 2,171 | 2,021 | |
| Accumulated deficit | −1,360 | −1,583 | −1,976 | −2,015 | −2,011 | |
| Accumulated other comprehensive income | 900,000 | 100,000 | −406,000 | 0 | — | |
| Total stockholders equity | 498 | 262 | 510 | 160 | −40 | |
| Total liabilities and stockholders equity | 3,366 | 3,015 | 3,187 | 2,520 | 2,086 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2026 2026-01-31 | FY 2025 2025-01-31 | FY 2024 2024-01-31 | FY 2023 2023-01-31 | FY 2022 2022-01-31 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 129 | 115 | 110 | 83 | 55 | |
| Share-based compensation expense | 298 | 306 | 239 | 158 | 78 | |
| Non-cash lease expense | 37 | 33 | 38 | 39 | 33 | |
| Change in fair value of equity warrants and investments | 3 | −2 | −13 | 13 | 0 | |
| Provision for deferred taxes | 29 | −258 | 0 | 0 | — | |
| Unrealized foreign currency (gains) losses, net | −200,000 | 1 | −400,000 | 0 | 0 | |
| Other adjustments | 8 | 1 | 4 | 1 | 595,000 | |
| Accounts receivable | −53 | −15 | −27 | −3 | −21 | |
| Inventories | −28 | −118 | −41 | −115 | −42 | |
| Prepaid expenses and other current assets | −22 | −14 | −50 | −11 | −7 | |
| Other non-current assets | −4 | 4 | −30 | 1 | −5 | |
| Trade accounts payable | 45 | 71 | 72 | 147 | 84 | |
| Accrued expenses and other current liabilities | 53 | 110 | 152 | 8 | 129 | |
| Operating lease liabilities | −34 | −32 | −27 | −22 | −20 | |
| Other long-term liabilities | 7 | 1 | 21 | −2 | −18 | |
| Net cash provided by operating activities | 692 | 596 | 486 | 350 | 192 | |
| Capital expenditures | −129 | −144 | −143 | −230 | −183 | |
| Proceeds from sales and maturities of marketable securities | 24 | 538 | 3,078 | 200 | 0 | |
| Purchases of marketable securities | −41 | 0 | −3,222 | −544 | 0 | |
| Other investing activities | −5 | 0 | −400,000 | −1 | 0 | |
| Net cash (used in) provided by investing activities | −152 | 395 | −287 | −616 | −193 | |
| Repurchases of common stock | −263 | −943 | 0 | 0 | — | |
| Income taxes paid for, net of proceeds from, parent reorganization transaction | −9 | −52 | 61 | 0 | — | |
| Payments of secondary offering costs | −1 | −1 | 0 | 0 | — | |
| Principal repayments of finance lease obligations | −200,000 | −900,000 | −500,000 | −681,000 | −869,000 | |
| Capital contribution from parent reorganization transaction | 0 | 0 | 22 | 0 | 0 | |
| Payments for tax sharing agreement with related parties | 0 | 0 | −10 | −3 | 44 | |
| Other financing activities | −3 | 0 | −200,000 | −3 | 0 | |
| Net cash (used in) provided by financing activities | −276 | −997 | 72 | −7 | 41 | |
| Effect of exchange rate changes on cash and cash equivalents | 500,000 | −600,000 | 200,000 | 0 | 0 | |
| Net increase (decrease) in cash and cash equivalents | 264 | −6 | 271 | −272 | 40 |